Rare fungal infections in grafts under review
NCT ID NCT07143409
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks back at 300 cases of fungal infections in vascular grafts from 12 French hospitals over 10 years. Researchers want to understand how these infections are treated and what affects patient survival. The goal is to find factors that lead to better outcomes for this rare but serious condition.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors identify the best treatments for rare but deadly fungal infections in vascular grafts.
- What could go wrong
- This is a retrospective study, not a clinical trial testing a new treatment. It only looks at past data, so it cannot prove what works best.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUNGAL INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Bordeaux
Bordeaux, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can one Mega-Dose of an antifungal beat a deadly infection in AIDS patients?
- New score could help doctors spot fungal pneumonia faster
- New gel shows promise for ugly toenail fungus
- Cord blood cells engineered to fight deadly mold in first human test
- New drug could shield transplant patients from deadly fungal infections
- Hidden fungal threat in COVID-19 ICU patients revealed